These effects would lead to inhibition of EMT (increased E-cadherin and decreased N-cadherin) and prevention of extracellular matrix degradation (increased TIMP-1 and decreased MMP2, 9), and then suppress the migration and invasion of HCC cells. The gene discussed is CDH2; the disease is hepatocellular carcinoma.